Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis.

Boor PPC, Sideras K, Biermann K, Hosein Aziz M, Levink IJM, Mancham S, Erler NS, Tang X, van Eijck CH, Bruno MJ, Sprengers D, Zang X, Kwekkeboom J.

Br J Cancer. 2020 Feb 19. doi: 10.1038/s41416-020-0755-4. [Epub ahead of print]

PMID:
32071413
2.

Diagnostic yield and agreement on fine-needle specimens from solid pancreatic lesions : comparing the smear technique to liquid-based cytology.

van Riet PA, Quispel R, Cahen DL, Snijders-Kruisbergen MC, van Loenen P, Erler NS, Poley JW, van Driel LMJW, Mulder SA, Veldt BJ, Leeuwenburgh I, Anten MGF, Honkoop P, Thijssen AY, Hol L, Hadithi M, Fitzpatrick CE, Schot I, Bergmann JF, Bhalla A, Bruno MJ, Biermann K.

Endosc Int Open. 2020 Feb;8(2):E155-E162. doi: 10.1055/a-1038-4103. Epub 2020 Jan 22.

3.

Frequency and power stabilization of a terahertz quantum-cascade laser using near-infrared optical excitation.

Alam T, Wienold M, Lü X, Biermann K, Schrottke L, Grahn HT, Hübers HW.

Opt Express. 2019 Dec 9;27(25):36846-36854. doi: 10.1364/OE.27.036846.

PMID:
31873456
4.

Endoscopic ultrasound and fine-needle aspiration for the detection of residual nodal disease after neoadjuvant chemoradiotherapy for esophageal cancer.

van der Bogt RD, van der Wilk BJ, Poley JW, Krishnadath KK, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, Bruno MJ, Biermann K, van Lanschot JJB, Spaander MCW.

Endoscopy. 2019 Dec 9. doi: 10.1055/a-1065-1759. [Epub ahead of print]

PMID:
31816658
5.

External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer.

Brinkmann S, Noordman BJ, Hölscher AH, Biermann K, van Klaveren D, Bollschweiler E, Pütz K, van Lanschot JJB, Drebber U.

Ann Surg Oncol. 2019 Nov 5. doi: 10.1245/s10434-019-08024-0. [Epub ahead of print]

PMID:
31691114
6.

Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.

van der Wilk BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, Nieuwenhuijzen GAP, Sosef MN, van Berge Henegouwen MI, Lagarde SM, Spaander MCW, Valkema R, Biermann K, Wijnhoven BPL, van der Gaast A, van Lanschot JJB, Doukas M, Nikkessen S, Luyer M, Schoon EJ, Roef MJ, van Lijnschoten I, Oostenbrug LE, Riedl RG, Gisbertz SS, Krishnadath KK, Bennink RJ, Meijer SL; Collaborators:.

Ann Surg. 2019 Oct 4. doi: 10.1097/SLA.0000000000003636. [Epub ahead of print]

PMID:
31592898
7.

Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study.

Nieuwenburg SAV, Waddingham WW, Graham D, Rodriguez-Justo M, Biermann K, Kuipers EJ, Banks M, Jansen M, Spaander MCW.

BMJ Open. 2019 Sep 18;9(9):e032013. doi: 10.1136/bmjopen-2019-032013.

8.

Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus.

van der Wel MJ, Klaver E, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Biermann K, Brosens L, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten G, Moll F, Ooms A, Tijssen JG, Bergman J, Meijer SL.

United European Gastroenterol J. 2019 Aug;7(7):889-896. doi: 10.1177/2050640619853441. Epub 2019 May 21.

9.

Granular dot-like staining with MLH1 immunohistochemistry is a clone-dependent artefact.

Dasgupta S, Ewing-Graham PC, Groenendijk FH, Stam O, Biermann KE, Doukas M, Dubbink HJ, van Velthuysen MF, Dinjens WNM, Van Bockstal MR.

Pathol Res Pract. 2020 Jan;216(1):152581. doi: 10.1016/j.prp.2019.152581. Epub 2019 Aug 5.

PMID:
31402167
10.

Tumor microRNA-126 controls cell viability and associates with poor survival in patients with esophageal adenocarcinoma.

Toxopeus E, Lynam-Lennon N, Biermann K, Dickens G, de Ruiter PE, van Lanschot J, Reynolds JV, Wijnhoven B, O'Sullivan J, van der Laan L.

Exp Biol Med (Maywood). 2019 Oct;244(14):1210-1219. doi: 10.1177/1535370219868671. Epub 2019 Aug 7. No abstract available.

PMID:
31390899
11.

Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels.

Sideras K, de Man RA, Harrington SM, Polak WG, Zhou G, Schutz HM, Pedroza-Gonzalez A, Biermann K, Mancham S, Hansen BE, Bart Takkenberg R, van Vuuren AJ, Pan Q, Ijzermans JNM, Sleijfer S, Sprengers D, Dong H, Kwekkeboom J, Bruno MJ.

Sci Rep. 2019 Jul 23;9(1):10677. doi: 10.1038/s41598-019-47235-z.

12.

Agreement on endoscopic ultrasonography-guided tissue specimens: Comparing a 20-G fine-needle biopsy to a 25-G fine-needle aspiration needle among academic and non-academic pathologists.

van Riet PA, Cahen DL, Biermann K, Hansen B, Larghi A, Rindi G, Fellegara G, Arcidiacono P, Doglioni C, Liberta Decarli N, Iglesias-Garcia J, Abdulkader I, Lazare Iglesias H, Kitano M, Chikugo T, Yasukawa S, van der Valk H, Nguyen NQ, Ruszkiewicz A, Giovannini M, Poizat F, van der Merwe S, Roskams T, Santo E, Marmor S, Chang K, Lin F, Farrell J, Robert M, Bucobo JC, Heimann A, Baldaque-Silva F, Fernández Moro C, Bruno MJ.

Dig Endosc. 2019 Nov;31(6):690-697. doi: 10.1111/den.13424. Epub 2019 Jul 10.

13.

Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.

Suzuki L, Ten Kate FJC, Gotink AW, Stoop H, Doukas M, Nieboer D, Spaander MCW, van Lanschot JJB, van Wijnhoven BPL, Koch AD, Bruno MJ, Looijenga LHJ, Biermann K.

PLoS One. 2019 Jul 8;14(7):e0219494. doi: 10.1371/journal.pone.0219494. eCollection 2019.

14.

Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma?

Gotink AW, Ten Kate FJ, Doukas M, Wijnhoven BP, Bruno MJ, Looijenga LH, Koch AD, Biermann K.

United European Gastroenterol J. 2019 Mar;7(2):261-269. doi: 10.1177/2050640618817693. Epub 2018 Dec 6.

15.

[Acute liver failure due to food supplements].

Peters CP, den Hoed CM, Coenen S, Biermann KE, de Man RA.

Ned Tijdschr Geneeskd. 2019 Apr 10;163. pii: D3522. Dutch.

PMID:
31050266
16.

Accuracy of 18F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.

Valkema MJ, Noordman BJ, Wijnhoven BPL, Spaander MCW, Biermann K, Lagarde SM, Bennink RJ, Schreurs WMJ, Roef MJ, Hobbelink MGG, Janssen MJR, Graven LH, van Lanschot JJB, Valkema R.

J Nucl Med. 2019 Nov;60(11):1553-1559. doi: 10.2967/jnumed.118.224196. Epub 2019 Mar 15.

PMID:
30877177
17.

Wideband, high-resolution terahertz spectroscopy by light-induced frequency tuning of quantum-cascade lasers.

Alam T, Wienold M, Lü X, Biermann K, Schrottke L, Grahn HT, Hübers HW.

Opt Express. 2019 Feb 18;27(4):5420-5432. doi: 10.1364/OE.27.005420.

PMID:
30876146
18.

Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer.

Toxopeus ELA, de Man FM, Krak N, Biermann K, Nieuweboer AJM, Friberg LE, Oomen-de Hoop E, van Lanschot JJB, Shapiro J, Wijnhoven BPL, Mathijssen RHJ.

Cancers (Basel). 2019 Feb 1;11(2). pii: E173. doi: 10.3390/cancers11020173.

19.

Resonant Second-Order Nonlinear Terahertz Response of Gallium Arsenide.

Ghalgaoui A, Reimann K, Woerner M, Elsaesser T, Flytzanis C, Biermann K.

Phys Rev Lett. 2018 Dec 28;121(26):266602. doi: 10.1103/PhysRevLett.121.266602.

PMID:
30636116
20.

Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma.

Ma B, Chen K, Liu P, Li M, Liu J, Sideras K, Sprengers D, Biermann K, Wang W, IJzermans JNM, Cao W, Kwekkeboom J, Peppelenbosch MP, Pan Q.

J Mol Med (Berl). 2019 Jan;97(1):77-88. doi: 10.1007/s00109-018-1717-7. Epub 2018 Nov 19.

21.

Cholecystectomy Risk in Crohn's Disease Patients After Ileal Resection: a Long-term Nationwide Cohort Study.

Goet JC, Beelen EMJ, Biermann KE, Gijsbers AH, Schouten WR, van der Woude CJ, de Vries AC.

J Gastrointest Surg. 2019 Sep;23(9):1840-1847. doi: 10.1007/s11605-018-4028-y. Epub 2018 Nov 8.

22.

A multicenter randomized trial comparing a 25-gauge EUS fine-needle aspiration device with a 20-gauge EUS fine-needle biopsy device.

van Riet PA, Larghi A, Attili F, Rindi G, Nguyen NQ, Ruszkiewicz A, Kitano M, Chikugo T, Aslanian H, Farrell J, Robert M, Adeniran A, Van Der Merwe S, Roskams T, Chang K, Lin F, Lee JG, Arcidiacono PG, Petrone M, Doglioni C, Iglesias-Garcia J, Abdulkader I, Giovannini M, Bories E, Poizat F, Santo E, Scapa E, Marmor S, Bucobo JC, Buscaglia JM, Heimann A, Wu M, Baldaque-Silva F, Moro CF, Erler NS, Biermann K, Poley JW, Cahen DL, Bruno MJ.

Gastrointest Endosc. 2019 Feb;89(2):329-339. doi: 10.1016/j.gie.2018.10.026. Epub 2018 Oct 24.

PMID:
30367877
23.

Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma.

Liu P, Cao W, Ma B, Li M, Chen K, Sideras K, Duitman JW, Sprengers D, Khe Tran TC, Ijzermans JNM, Biermann K, Verheij J, Spek CA, Kwekkeboom J, Pan Q, Peppelenbosch MP.

Carcinogenesis. 2019 Mar 12;40(1):155-163. doi: 10.1093/carcin/bgy130.

PMID:
30325409
24.

Management of psychogenic non-epileptic seizures: a multidisciplinary approach.

Gasparini S, Beghi E, Ferlazzo E, Beghi M, Belcastro V, Biermann KP, Bottini G, Capovilla G, Cervellione RA, Cianci V, Coppola G, Cornaggia CM, De Fazio P, De Masi S, De Sarro G, Elia M, Erba G, Fusco L, Gambardella A, Gentile V, Giallonardo AT, Guerrini R, Ingravallo F, Iudice A, Labate A, Lucenteforte E, Magaudda A, Mumoli L, Papagno C, Pesce GB, Pucci E, Ricci P, Romeo A, Quintas R, Sueri C, Vitaliti G, Zoia R, Aguglia U.

Eur J Neurol. 2019 Feb;26(2):205-e15. doi: 10.1111/ene.13818. Epub 2018 Nov 29. Review.

PMID:
30300463
25.

Fast Detection of a Weak Signal by a Stochastic Resonance Induced by a Coherence Resonance in an Excitable GaAs/Al_{0.45}Ga_{0.55}As Superlattice.

Shao Z, Yin Z, Song H, Liu W, Li X, Zhu J, Biermann K, Bonilla LL, Grahn HT, Zhang Y.

Phys Rev Lett. 2018 Aug 24;121(8):086806. doi: 10.1103/PhysRevLett.121.086806.

PMID:
30192582
26.

Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms.

Vandamme T, Beyens M, Boons G, Schepers A, Kamp K, Biermann K, Pauwels P, De Herder WW, Hofland LJ, Peeters M, Van Camp G, Op de Beeck K.

Endocr Relat Cancer. 2019 Jan 1;26(1):1-12. doi: 10.1530/ERC-18-0120.

PMID:
30021865
27.

Prognostic value of intra-tumoral CD8+ /FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis.

Sideras K, Galjart B, Vasaturo A, Pedroza-Gonzalez A, Biermann K, Mancham S, Nigg AL, Hansen BE, Stoop HA, Zhou G, Verhoef C, Sleijfer S, Sprengers D, Kwekkeboom J, Bruno MJ.

J Surg Oncol. 2018 Jul;118(1):68-76. doi: 10.1002/jso.25091. Epub 2018 Jun 7.

28.

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.

Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, Biermann K, van der Gaast A, van Hillegersberg R, Hulshof MCCM, Krishnadath KK, Lagarde SM, Nieuwenhuijzen GAP, Oostenbrug LE, Siersema PD, Schoon EJ, Sosef MN, Steyerberg EW, van Lanschot JJB; SANO study group.

Lancet Oncol. 2018 Jul;19(7):965-974. doi: 10.1016/S1470-2045(18)30201-8. Epub 2018 Jun 1.

PMID:
29861116
29.

Improved Progression Prediction in Barrett's Esophagus With Low-grade Dysplasia Using Specific Histologic Criteria.

Ten Kate FJC, Nieboer D, Ten Kate FJW, Doukas M, Bruno MJ, Spaander MCW, Looijenga LHJ, Biermann K; ProBar study group and Palga Group.

Am J Surg Pathol. 2018 Jul;42(7):918-926. doi: 10.1097/PAS.0000000000001066.

PMID:
29697438
30.

Confirmation of a metastasis-specific microRNA signature in primary colon cancer.

Coebergh van den Braak RRJ, Sieuwerts AM, Lalmahomed ZS, Smid M, Wilting SM, Bril SI, Xiang S, van der Vlugt-Daane M, de Weerd V, van Galen A, Biermann K, van Krieken JHJM, Kloosterman WP, Foekens JA; MATCH study group*, Martens JWM, IJzermans JNM.

Sci Rep. 2018 Mar 27;8(1):5242. doi: 10.1038/s41598-018-22532-1.

31.

Public Health since the beginning: Neonatal incubators safety in a clinical setting.

Fattorini M, Buonocore G, Lenzi D, Burgassi S, Cardaci RMR, Biermann KP, Cevenini G, Messina G.

J Infect Public Health. 2018 Nov - Dec;11(6):788-792. doi: 10.1016/j.jiph.2018.03.001. Epub 2018 Mar 22.

32.

How to prepare, handle, read, and improve EUS-FNA and fine-needle biopsy for solid pancreatic lesions: The pathologist's role.

Biermann K, Lozano Escario MD, Hébert-Magee S, Rindi G, Doglioni C.

Endosc Ultrasound. 2017 Dec;6(Suppl 3):S95-S98. doi: 10.4103/eus.eus_71_17. No abstract available.

33.

Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining.

van der Wel MJ, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus GJA, Visser M, Ten Kate FJ, Biermann K, Brosens LAA, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten GI, Moll FCP, Ooms AHAG, van der Valk H, Tijssen JG, Bergman JJ, Meijer SL.

Histopathology. 2018 May;72(6):1015-1023. doi: 10.1111/his.13462. Epub 2018 Feb 28.

PMID:
29314176
34.

Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma.

Ten Kate FJC, Suzuki L, Dorssers LCJ, Dinjens WNM, Jones DTW, Nieboer D, Doukas M, Van Lanschot JJB, Wijnhoven BPL, Looijenga LHJ, Biermann K.

Oncotarget. 2017 Oct 24;8(61):104123-104135. doi: 10.18632/oncotarget.22021. eCollection 2017 Nov 28.

35.

Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial.

Noordman BJ, Verdam MGE, Lagarde SM, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch OR, Ten Kate FJW, Creemers GM, Punt CJA, Plukker JTM, Verheul HMW, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A, Sprangers MAG, van Lanschot JJB.

J Clin Oncol. 2018 Jan 20;36(3):268-275. doi: 10.1200/JCO.2017.73.7718. Epub 2017 Nov 21.

PMID:
29161204
36.

Germline variant in MSX1 identified in a Dutch family with clustering of Barrett's esophagus and esophageal adenocarcinoma.

van Nistelrooij AMJ, van Marion R, van Ijcken WFJ, de Klein A, Wagner A, Biermann K, Spaander MCW, van Lanschot JJB, Dinjens WNM, Wijnhoven BPL.

Fam Cancer. 2018 Jul;17(3):435-440. doi: 10.1007/s10689-017-0054-2.

37.

High Prevalence of Barrett's Esophagus and Esophageal Squamous Cell Carcinoma After Repair of Esophageal Atresia.

Vergouwe FWT, IJsselstijn H, Biermann K, Erler NS, Wijnen RMH, Bruno MJ, Spaander MCW.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):513-521.e6. doi: 10.1016/j.cgh.2017.11.008. Epub 2017 Nov 11.

PMID:
29133255
38.

Histological Assessment of Gonads in DSD: Relevance for Clinical Management.

Spoor JA, Oosterhuis JW, Hersmus R, Biermann K, Wolffenbuttel KP, Cools M, Kazmi Z, Ahmed SF, Looijenga LHJ.

Sex Dev. 2018;12(1-3):106-122. doi: 10.1159/000481757. Epub 2017 Nov 3. Review.

PMID:
29131109
39.

Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis.

Janmaat VT, van Olphen SH, Biermann KE, Looijenga LHJ, Bruno MB, Spaander MCW.

PLoS One. 2017 Oct 23;12(10):e0186305. doi: 10.1371/journal.pone.0186305. eCollection 2017. Review.

40.

Comparison of pancreatic histology specimens obtained by EUS 19G versus 22G core biopsy needles: A prospective multicentre study among experienced pathologists.

Petrone MC, Poley JW, Bonzini M, Abdulkader I, Biermann K, Monges G, Rindi G, Doglioni C, Bruno MJ, Giovannini M, Iglesias-Garcia J, Larghi A, Arcidiacono PG.

United European Gastroenterol J. 2017 Oct;5(6):854-858. doi: 10.1177/2050640616687231. Epub 2017 Jan 11.

41.

High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.

Coebergh van den Braak RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, Bril SI, van Galen A, Smid M, Biermann K, van Krieken JHJM, Kloosterman WP, Foekens JA, Goel A, Martens JWM, IJzermans JNM; MATCH study group.

PLoS One. 2017 Sep 28;12(9):e0185607. doi: 10.1371/journal.pone.0185607. eCollection 2017.

42.

Multiparameter Investigation of a 46,XX/46,XY Tetragametic Chimeric Phenotypical Male Patient with Bilateral Scrotal Ovotestes and Ovulatory Activity.

van Bever Y, Wolffenbuttel KP, Brüggenwirth HT, Blom E, de Klein A, Eussen BHJ, van der Windt F, Hannema SE, Dessens AB, Dorssers LCJ, Biermann K, Hersmus R, de Rijke YB, Looijenga LHJ.

Sex Dev. 2018;12(1-3):145-154. doi: 10.1159/000479946. Epub 2017 Sep 20.

43.

Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer.

Noordman BJ, Wijnhoven BPL, Lagarde SM, Biermann K, van der Gaast A, Spaander MCW, Valkema R, van Lanschot JJB.

Dis Esophagus. 2017 Dec 1;30(12):1-8. doi: 10.1093/dote/dox100. Review.

PMID:
28881890
44.

Terahertz quantum-cascade lasers as high-power and wideband, gapless sources for spectroscopy.

Röben B, Lü X, Hempel M, Biermann K, Schrottke L, Grahn HT.

Opt Express. 2017 Jul 10;25(14):16282-16290. doi: 10.1364/OE.25.016282.

PMID:
28789135
45.

Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma.

Ten Kate FJC, van Olphen SH, Bruno MJ, Wijnhoven BPL, van Lanschot JJB, Looijenga LHJ, Fitzgerald RC, Biermann K.

Br J Surg. 2017 Sep;104(10):1327-1337. doi: 10.1002/bjs.10553. Epub 2017 Jul 10.

46.

Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin-10 Receptor.

Veenbergen S, van Leeuwen MA, Driessen GJ, Kersseboom R, de Ruiter LF, Raatgeep RHC, Lindenbergh-Kortleve DJ, Simons-Oosterhuis Y, Biermann K, Halley DJJ, de Ridder L, Escher JC, Samsom JN.

J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):e5-e15. doi: 10.1097/MPG.0000000000001559.

PMID:
28644354
47.

A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer.

Kloosterman WP, Coebergh van den Braak RRJ, Pieterse M, van Roosmalen MJ, Sieuwerts AM, Stangl C, Brunekreef R, Lalmahomed ZS, Ooft S, van Galen A, Smid M, Lefebvre A, Zwartkruis F, Martens JWM, Foekens JA, Biermann K, Koudijs MJ, Ijzermans JNM, Voest EE.

Cancer Res. 2017 Jul 15;77(14):3814-3822. doi: 10.1158/0008-5472.CAN-16-3563. Epub 2017 May 16.

48.

Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer.

Sideras K, Biermann K, Yap K, Mancham S, Boor PPC, Hansen BE, Stoop HJA, Peppelenbosch MP, van Eijck CH, Sleijfer S, Kwekkeboom J, Bruno MJ.

Int J Cancer. 2017 Aug 1;141(3):572-582. doi: 10.1002/ijc.30760. Epub 2017 May 19.

49.

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples.

van Nistelrooij AM, van Marion R, Koppert LB, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Wijnhoven BP, Dinjens WN.

BMC Res Notes. 2017 Apr 4;10(1):144. doi: 10.1186/s13104-017-2456-5.

50.

Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy.

Noordman BJ, van Klaveren D, van Berge Henegouwen MI, Wijnhoven BPL, Gisbertz SS, Lagarde SM, van der Gaast A, Hulshof MCCM, Biermann K, Steyerberg EW, van Lanschot JJB; also on behalf of the CROSS-study group.

Ann Surg. 2018 May;267(5):892-897. doi: 10.1097/SLA.0000000000002240.

PMID:
28350565

Supplemental Content

Loading ...
Support Center